Trial Profile
Evaluation of the Occurence of Thrombotic and Bleeding Events After Coronary Angioplasty With Stent According to Aspirin and Clopidogrel Platelet Reactivity Assessed by a Point of Care Assay in the Cathlab (the Verifynow French Registry).
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 09 Nov 2021
Price :
$35
*
At a glance
- Drugs Aspirin (Primary) ; Clopidogrel (Primary)
- Indications Coronary stent thrombosis
- Focus Therapeutic Use
- Acronyms VERIFRENCHY
- 24 Jun 2015 Status changed from active, no longer recruiting to completed as per ClinicalTrials.gov record.
- 05 Aug 2009 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 01 Oct 2008 New trial record.